RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jacobson Pharma Corporation Stock

Jacobson Pharma Corporation P/E 2025

Jacobson Pharma Corporation P/E

4.24

Ticker

2633.HK

ISIN

KYG677291067

As of Feb 8, 2025, Jacobson Pharma Corporation's P/E ratio was 4.24, a -17.03% change from the 5.11 P/E ratio recorded in the previous year.

The Jacobson Pharma Corporation P/E history

Jacobson Pharma Corporation Aktienanalyse

What does Jacobson Pharma Corporation do?

Jacobson Pharma Corporation ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Jacobson Pharma Corporation's P/E Ratio

The Price to Earnings (P/E) Ratio of Jacobson Pharma Corporation is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Jacobson Pharma Corporation's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Jacobson Pharma Corporation is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Jacobson Pharma Corporation’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Jacobson Pharma Corporation stock

What is the price-to-earnings ratio of Jacobson Pharma Corporation?

The price-earnings ratio of Jacobson Pharma Corporation is currently 4.24.

How has the price-earnings ratio of Jacobson Pharma Corporation changed compared to last year?

The price-to-earnings ratio of Jacobson Pharma Corporation has increased by -17.03% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Jacobson Pharma Corporation high compared to other companies?

Yes, the price-to-earnings ratio of Jacobson Pharma Corporation is high compared to other companies.

How does an increase in the price-earnings ratio of Jacobson Pharma Corporation affect the company?

An increase in the price-earnings ratio of Jacobson Pharma Corporation would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Jacobson Pharma Corporation affect the company?

A decrease in the price-earnings ratio of Jacobson Pharma Corporation would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Jacobson Pharma Corporation?

Some factors that influence the price-earnings ratio of Jacobson Pharma Corporation are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Jacobson Pharma Corporation pay?

Over the past 12 months, Jacobson Pharma Corporation paid a dividend of 0.03 HKD . This corresponds to a dividend yield of about 2.22 %. For the coming 12 months, Jacobson Pharma Corporation is expected to pay a dividend of 0.03 HKD.

What is the dividend yield of Jacobson Pharma Corporation?

The current dividend yield of Jacobson Pharma Corporation is 2.22 %.

When does Jacobson Pharma Corporation pay dividends?

Jacobson Pharma Corporation pays a quarterly dividend. This is distributed in the months of September, January, October, March.

How secure is the dividend of Jacobson Pharma Corporation?

Jacobson Pharma Corporation paid dividends every year for the past 8 years.

What is the dividend of Jacobson Pharma Corporation?

For the upcoming 12 months, dividends amounting to 0.03 HKD are expected. This corresponds to a dividend yield of 2.22 %.

In which sector is Jacobson Pharma Corporation located?

Jacobson Pharma Corporation is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jacobson Pharma Corporation kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jacobson Pharma Corporation from 4/2/2025 amounting to 0.035 HKD, you needed to have the stock in your portfolio before the ex-date on 2/25/2025.

When did Jacobson Pharma Corporation pay the last dividend?

The last dividend was paid out on 4/2/2025.

What was the dividend of Jacobson Pharma Corporation in the year 2024?

In the year 2024, Jacobson Pharma Corporation distributed 0.049 HKD as dividends.

In which currency does Jacobson Pharma Corporation pay out the dividend?

The dividends of Jacobson Pharma Corporation are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jacobson Pharma Corporation

Our stock analysis for Jacobson Pharma Corporation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jacobson Pharma Corporation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.